Market Overview

UPDATE: Auxilium Posts Upbeat Q3 Profit

Related AUXL
UPDATE: Jefferies Reiterates On Auxilium Pharmaceuticals, Inc. As Restructuring Realigns Costs With Commercial Opportunities
Auxilium Pharmaceuticals, Inc. Announces Corporate Restructuring Designed To Streamline Operations, Cutting 30% Of Jobs

Auxilium Pharmaceuticals (NASDAQ: AUXL) reported an upbeat third-quarter profit and narrowed its revenue outlook for the full year.

Auxilium now projects full-year revenue of $370 million to $401 million, versus its prior forecast of $363 million to $405 million.

Auxilium posted a quarterly net loss of $28.9 million, or $0.59 per share, versus a year-ago loss of $10.5 million, or $0.21 per share. Excluding items, it earned $0.17 per share.

Its net revenue rose 52% to $108.1 million. However, analysts were expecting a profit of $0.15 per share on revenue of $103.7 million.

Auxilium shares gained 5.55% to $18.25 in pre-market trading.

Posted-In: profitEarnings News Guidance

 

Related Articles (AUXL)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters